Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10821867 | 0.77 | OPRM1 (0.56) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL14899046 | 0.72 | OPRM1 (0.56) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL10603880 | 0.72 | OPRM1 (0.59) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL21725626 | 0.72 | OPRM1 (0.40) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL791817 | 0.72 | SLC6A4 (0.47) | SLC6A4OPRM1OPRD1DPP4AKR1C1 | |
| SCHEMBL10605630 | 0.71 | DRD3 (0.37) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL1040539 | 0.71 | OPRM1 (0.54) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL16024156 | 0.71 | OPRM1 (0.54) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL1040389 | 0.71 | OPRM1 (0.54) | SLC6A4DRD3OPRM1OPRK1OPRL1 | |
| SCHEMBL3815508 | 0.70 | SLC6A2 (0.45) | SLC6A4DRD3OPRM1OPRD1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104039753-B | The compositions of phenylcycloalkyl methylamine derivative, synthesis and using method | 雷维瓦药品公司 | 2016-09-14 | — | — | CN | disclosed |